Table 7.
Study Design | Country | No. | Age Group | Disease | Daily Dosage (g/d) | Duration | Rating Scale | Outcome | |
---|---|---|---|---|---|---|---|---|---|
Ayton et al., 2004 [130] | Case report | UK | 1 | 15 y | AN | EPA 1 g/day | 12 weeks | BMI | Improvements in both weight and food intake. |
Ayton et al., 2004 [131] | Pilot open case series | UK | 10 | 13–22 y | AN | EPA 1 g/day | 6–8 weeks | BMI | Improvement of general functioning and mood. |
BMI: Body mass index.